Ruth Tatevossian

7.7k citations
29 papers · 1.0k indexed · h-index 13
Topics
Glioma Diagnosis and Treatment (15 papers)Chromatin Remodeling and Cancer (6 papers)Epigenetics and DNA Methylation (5 papers)

In The Last Decade

Ruth Tatevossian

26 papers receiving 999 citations

Peers

Ruth Tatevossian
Comparison fields: 5 of 58
  • Genetics 675
  • Molecular Biology 442
  • Neurology 386
  • Cancer Research 169
  • Pulmonary and Respiratory Medicine 131
Replace Julie Lejeune with:
Julie Lejeune France
John‐Paul Kilday United Kingdom
Pankaj Pathak India
Antony Michalski United Kingdom
Hilary Blair United States
Takafumi Nishizaki Japan
Catherine Godfraind Belgium
Hayato Ikota Japan
M. Eva Alonso Spain
Carl Koschmann United States
Ruth Tatevossian relative to Julie Lejeune France Julie Lejeune's profile →
Citations per field
00.5×2.6×
Julie Lejeune · 1×
Citations per year

Countries citing papers authored by Ruth Tatevossian

Since Specialization
Citations

This map shows the geographic impact of Ruth Tatevossian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Tatevossian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Tatevossian more than expected).

Fields of papers citing papers by Ruth Tatevossian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Tatevossian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Tatevossian. The network helps show where Ruth Tatevossian may publish in the future.

Co-authorship network of co-authors of Ruth Tatevossian

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Tatevossian. A scholar is included among the top collaborators of Ruth Tatevossian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Tatevossian. Ruth Tatevossian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 4
4 1
5 1
6 0
7 4
8 13
9 35
10 43
11 24
12 219
13 50
14 46
15 218
16 70
17 7
18 79
19 10
20 8

About Ruth Tatevossian

Ruth Tatevossian is a scholar working on Genetics, Neurology and Cancer Research, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (15 papers), Chromatin Remodeling and Cancer (6 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Genetics (675 citations), Neurology (386 citations) and Cancer Research (169 citations). Ruth Tatevossian has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include David W. Ellison, Amar Gajjar, Alberto Broniscer, Denise Sheer, Tim Forshew, Andrew Lawson, James Dalton, T. Alwyn Jones, Geoffrey Neale and Arzu Onar‐Thomas. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026